PA Blog

Evidence based surgery - CABG versus PCI - Cardiothoracic Surgery - Surgical Education

PCI versus CABG – The Syntax Trial

The SYNTAX trial is the landmark RCT for cardiothoracic surgeons. CABG versus PCI. In this international trial 1800 patients with three-vessel or left main coronary artery disease were randomly assigned to either revascularisation with CABG or PCI. Those undergoing PCI were found to be more likely to reach the primary end point of death from any cause, stroke, AMI, or repeat revascularisation.

Fundamentally allowing cardiothoracic surgeons to continue to crack chests and perform bypass surgery!

Interestingly the 10 year follow up has recently been published in the LANCET suggesting that CABG provides a significant survival benefit in patients with three-vessels disease, but not with left main coronary artery disease.

Check out the full articles at: Serruys P, Morice M, Kappetein P, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009; 360:961-972. DOI: 10.1056/NEJMoa0804626

Thuijs D, Kappetein A, Serruys P, et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. LANCET. 2019; 392: 818




You may also like…

Small AAA to repair or not to?

This is a great article for all those interested in vascular surgery! And helps explain why >5.5cm is the cut off point for AAA repair. This landmark study by the UK NHS clearly shows that early surgical intervention for small abdominal aortic aneurysms confers no survival benefit over surveillance.

read more